Summary: The Centers for Medicare & Medicaid Services modified its Transmyocardial Revascularization (TMR) coverage policy, with an effective date of May 15, 2026. Here's what billing teams need to know before that date.
CMS Transmyocardial Revascularization coverage policy governs Medicare payment for a surgical procedure used to treat refractory angina when coronary artery bypass grafting or angioplasty isn't an option. The policy does not list specific CPT or HCPCS codes in the data available for this update — we'll flag that clearly in the codes section below. If your practice or facility bills TMR services to Medicare patients, review this change carefully before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Transmyocardial Revascularization (TMR) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | High |
| Specialties Affected | Cardiac surgery, cardiothoracic surgery, interventional cardiology |
| Key Action | Audit your TMR claims and documentation against updated medical necessity criteria before May 15, 2026 |
CMS Transmyocardial Revascularization Coverage Criteria and Medical Necessity Requirements 2026
Transmyocardial revascularization is a laser-based cardiac procedure. Surgeons use a high-energy laser to create channels in the left ventricular wall. The goal is to relieve severe, chronic angina in patients who have no other surgical options.
CMS has covered TMR under specific medical necessity criteria for years. The modification effective May 15, 2026 signals a policy review — which typically means tightened documentation requirements, adjusted indications, or updated clinical evidence thresholds.
The source policy document does not include the full updated text in the data available for this post. What that means for your billing team: you can't assume the prior version's criteria still apply in full. Pull the current policy directly from the CMS coverage database and compare it against what you've been using.
What Medical Necessity Has Historically Required for TMR
Under prior CMS policy, TMR coverage required that patients meet a specific clinical profile. Medical necessity criteria have generally included all of the following:
| # | Covered Indication |
|---|---|
| 1 | Severe angina (typically Canadian Cardiovascular Society Class III or IV) that does not respond to maximal medical therapy |
| 2 | Evidence that the patient is not a candidate for conventional revascularization — either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI/angioplasty) |
| 3 | Documented reversible myocardial ischemia in the region to be treated |
| 4 | Left ventricular ejection fraction above a minimum threshold (historically 25–30%) |
| 5 | No recent myocardial infarction within a defined window before the procedure |
These criteria reflect the CMS Transmyocardial Revascularization coverage policy as it has been applied historically. If the May 2026 modification tightens or expands any of these thresholds, your documentation templates need to match the new version exactly — not the old one.
Prior Authorization for TMR Under Medicare
Medicare does not typically require prior authorization for inpatient surgical procedures in the traditional Medicare (fee-for-service) setting. However, Medicare Advantage plans operate differently. If your patient is enrolled in a Medicare Advantage plan, prior authorization requirements apply and vary by plan. Check each plan's requirements individually before scheduling.
For traditional Medicare TMR billing, medical necessity documentation at the time of claim submission is your primary protection against claim denial. Get that documentation right before the case, not after.
How the 2026 Modification Affects Reimbursement
Without the full updated policy text, it's not possible to state definitively whether reimbursement rates change with this modification. CMS procedure reimbursement for TMR flows through the Inpatient Prospective Payment System (IPPS) for hospital-based cases and through the Physician Fee Schedule for the surgeon's professional component. Neither rate changes automatically with a coverage policy modification — but coverage changes can affect which DRGs apply and whether claims pass medical review.
If CMS narrows the covered indications, claims that previously cleared medical review may now trigger additional documentation requests or denial. That's the financial exposure you're managing here.
CMS Transmyocardial Revascularization Exclusions and Non-Covered Indications
The policy data available for this post does not include a specific list of exclusions from the updated version. That's a gap — not a green light.
CMS has historically considered several TMR applications non-covered or investigational. Your billing team should be aware of the following categories that have triggered claim denial in the past:
Standalone TMR without documented failed medical therapy. CMS does not cover TMR as a first-line treatment. Patients must have exhausted maximal medical therapy before the procedure qualifies.
TMR combined with CABG in patients who are CABG candidates. When a patient is eligible for conventional revascularization, TMR does not add a separately covered benefit. CMS has treated combined TMR/CABG differently than standalone TMR. Know which scenario you're billing.
Percutaneous TMR (catheter-based approaches). This is a critical distinction. Surgical TMR — performed through a thoracotomy — has a different coverage status than percutaneous TMR performed via catheter. CMS has historically covered surgical TMR under specific criteria while treating percutaneous TMR as investigational. If your facility performs the catheter-based version, do not assume the same coverage policy applies.
Right ventricular TMR. Coverage has applied to left ventricular treatment. Right ventricular applications have not carried the same coverage status.
Review the updated policy against each of these categories before your next TMR case.
Coverage Indications at a Glance
The policy data provided does not include a detailed, indication-level breakdown from the updated document. The table below reflects the established CMS TMR coverage framework. Verify each row against the May 15, 2026 version before relying on it for billing decisions.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Surgical TMR for refractory angina (CCS Class III/IV), no CABG/PCI option | Covered (when criteria met) | See codes section | Full documentation of failed medical therapy required |
| Surgical TMR combined with CABG in non-CABG candidates | Covered (when criteria met) | See codes section | Patient must not be a standalone CABG candidate |
| Percutaneous (catheter-based) TMR | Historically non-covered / investigational | N/A | Different procedure — do not bill under surgical TMR codes |
| Right ventricular TMR | Not covered | N/A | Coverage has applied to left ventricle only |
| TMR without documented failed medical therapy | Not covered | N/A | Medical necessity requires exhausted medical options |
| TMR in patients eligible for conventional revascularization | Not covered | N/A | CABG or PCI eligibility disqualifies standalone TMR coverage |
CMS Transmyocardial Revascularization Billing Guidelines and Action Items 2026
The effective date of May 15, 2026 is your deadline. Here's exactly what to do before then.
1. Pull the updated CMS policy and compare it line by line against your current documentation templates.
Don't rely on memory or your current intake forms. The modification may have changed specific criteria — ejection fraction thresholds, angina class requirements, or the definition of "failed medical therapy." Your documentation templates need to reflect the new version, not the old one.
2. Audit pending and recent TMR claims for documentation completeness.
Look at TMR cases from the past 12 months. Check whether your documentation would survive scrutiny under the updated criteria. If you're seeing patterns — missing cardiology consult notes, incomplete prior treatment history, no documented reason CABG was contraindicated — fix that before the change takes effect.
3. Confirm which CPT codes your facility uses for TMR and verify their status under the updated policy.
The policy data for this post does not include specific codes. That's a problem for your billing team, not a pass. Contact your MAC (Medicare Administrative Contractor) directly, or access the full policy at app.payerpolicy.org/p/cms/120-v1. Know exactly which CPT codes apply to surgical TMR versus combined TMR/CABG before May 15, 2026.
4. Brief your cardiac surgery team on the updated criteria.
Claim denial on TMR usually starts with missing clinical documentation — not a billing error. Your cardiac surgeons and their documentation staff need to know what CMS requires before the procedure, not after the denial letter arrives. A 15-minute pre-surgery documentation checklist is worth more than a 90-day appeals process.
5. Separate your surgical TMR workflow from any percutaneous TMR cases.
These are different procedures with different coverage statuses. If your facility performs both, make sure charge capture routes them differently. Billing percutaneous TMR under surgical TMR codes is a compliance risk, not just a billing error.
6. Check Medicare Advantage plan requirements separately.
Traditional Medicare and Medicare Advantage follow different rules. For any TMR patient enrolled in a Medicare Advantage plan, call the plan before the procedure to confirm prior authorization requirements and their specific coverage policy for TMR. Don't assume CMS fee-for-service rules transfer.
7. Loop in your compliance officer if you have volume.
If TMR is a meaningful part of your cardiac surgery revenue, talk to your compliance officer before May 15, 2026. A coverage policy modification with incomplete public documentation is exactly the kind of situation where an internal review protects you.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Transmyocardial Revascularization Under CMS Policy
The policy data provided for this post does not include specific CPT, HCPCS, or ICD-10 codes. This is not an editorial choice — the source document did not supply code-level data for this update.
Do not use codes from this post as authoritative. Pull the full policy directly from CMS at app.payerpolicy.org/p/cms/120-v1. and identify the applicable codes from the official document.
What to Look For When You Access the Policy
When you review the full CMS TMR policy, you're looking for:
- The CPT code(s) for surgical transmyocardial revascularization (laser-based, thoracotomy approach)
- The CPT code(s) for TMR performed in combination with CABG, if covered separately
- Any HCPCS Level II codes that apply to the procedure or related services
- ICD-10-CM diagnosis codes that support medical necessity — specifically codes for chronic ischemic heart disease, refractory angina, and documentation of prior revascularization attempts
Your MAC may also have a local coverage determination (LCD) that supplements or refines the national policy. Check for an LCD from your specific MAC in addition to the national CMS policy. Regional contractors sometimes add documentation requirements that go beyond what the national policy states.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.